Tomorrow at 9.00 am France time @slice_inr, co-PI's @CostalatV@CarolineArquiz1@lapergue6@TudorGJovin will present primary results of LASTE (randomized trial of MT in large core pts. ASPECTS 0-5). Median core = 150 ml with 56% ASPECTS 0-2.Please join us: https://t.co/jQL4a0fdUU
Honored to present LASTE results @slice_inr together with @CostalatV@CarolineArquiz1@lapergue6. Strong benefit of thrombectomy within 7 hrs in unlimitedly large core.NNT 4.Equal benefit in ASPECTS 0-2 vs 3-5 & lower mortality.
No more reasons to exclude pts based on imaging !!
More evidence for thrombectomy for large core stroke. We need to decrease barriers to therapy. Reduce time wondering about ASPECTS and accelerate treatment. https://t.co/m8ns4c783b
The University of Oklahoma Department of Neurology invites you to join our wonderful faculty and residents to learn more about our program.
Looking forward to meeting all the amazing candidates! 🧠
#Match2024#Neurotwitter#Neurology
Scan QR code below for zoom link!
🗺🎓Large and small clinical trials: challenges and opportunities. It's inspiring to see #FutureStrokeleaders learning from the best. We're proud to see Future Stroke Leaders publication on key design elements of successful acute #ischemic#stroke treatment #trials. https://t.co/OBnqWk4tAP
💡Let us know in the comments what breakthroughs in #clinical #trials you're most excited about.
#clinicaltrials #learning #leaders